Ocular Evidence
Evidence database / Studies / kamiya-2022-low-myopia-evo-icl
MODERATE evidenceRETROSPECTIVEVerified evidence

A Nationwide Multicenter Study on 1-Year Outcomes of Posterior Chamber Phakic Intraocular Lens Implantation for Low Myopia

Kamiya K, Shimizu K, Igarashi A, Kitazawa Y, Kojima T, Nakamura T, Ichikawa K, Fukuoka S, Fujimoto K, Japan ICL Study Group · Frontiers in Medicine · 2022

Source
111enrolled patients*
172enrolled eyes*
1structured arms
365maximum standardized days follow-up

* Descriptive sum of reported arm counts. “≥” indicates that one or more arm counts were not reported; missing values are not treated as zero.

Study arm

EVO ICL for low myopia

ICLEVO Implantable Collamer Lens

Population

Patients
111
Eyes
172
Bilateral treatment
Not reported
Age range
Not reported
Sphere range
Not reported
Cylinder range
Not reported
Spherical equivalent
Not reported
Corneal thickness
Not reported

Eligibility definition

Inclusion
Low myopia or myopic astigmatism with manifest spherical equivalent of -3.00 D or less.

Exclusion
Not structured

Reported outcomes by follow-up

OutcomeFollow-upFollow-up sampleResultReported fractionProvenance
MRSE within ±0.50 D
predictability
1 year172 eyes91.0%denominator: 172 eyes
VERIFIED
Refraction within ±1.00 D
efficacy
1 year172 eyes100.0%denominator: 172 eyes
VERIFIED

Complications

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.